Furosemide Dosage and Administration for Edema and Hypertension
For patients with edema or hypertension, the recommended initial oral dose of furosemide is 20-80 mg given as a single dose, with subsequent dosing adjusted based on clinical response. 1
Dosing for Edema
Adults
- Initial dose: 20-80 mg orally as a single dose 1
- If needed, the same dose can be administered 6-8 hours later or increased 1
- Dose may be increased by 20-40 mg increments, given no sooner than 6-8 hours after the previous dose 1
- Once optimal response is determined, administer the individualized dose once or twice daily (e.g., 8 AM and 2 PM) 1
- In severe edematous states, doses may be carefully titrated up to 600 mg/day 1
- For efficient and safe mobilization of edema, consider giving furosemide on 2-4 consecutive days each week 1
Pediatric Patients
- Initial dose: 2 mg/kg body weight as a single dose 1
- If response is inadequate, may increase by 1-2 mg/kg no sooner than 6-8 hours after previous dose 1
- Maximum recommended dose: 6 mg/kg body weight 1
Heart Failure with Congestion
- For acute heart failure or decompensated heart failure in diuretic-naïve patients: 20-40 mg IV furosemide 2
- For patients already on chronic diuretic therapy: initial IV dose should be at least equivalent to their oral dose 2
- Loop diuretics are recommended for patients with evidence of congestion or fluid retention 3
- Maintenance diuretics should be considered in patients with history of congestion to prevent recurrent symptoms 3
- Treatment goal: eliminate clinical evidence of fluid retention using the lowest effective dose to maintain euvolemia 3
Dosing for Hypertension
Adults
- Initial dose: 80 mg daily, usually divided into 40 mg twice a day 1
- Adjust dosage according to blood pressure response 1
- If response is inadequate, add other antihypertensive agents 1
- When adding furosemide to existing antihypertensive regimen, reduce dosage of other agents by at least 50% to prevent excessive blood pressure drop 1
Geriatric Patients
- Start at the lower end of the dosing range for both edema and hypertension 1
- Careful monitoring is required due to increased risk of dehydration and electrolyte imbalances 1
Administration Considerations
Intravenous Administration
- For acute heart failure with congestion: 20-40 mg IV bolus initially 3, 2
- In patients with volume overload, dose may be increased based on renal function and history of chronic oral diuretic use 3
- Total furosemide dose should remain <100 mg in first 6 hours and <240 mg during first 24 hours 3
- Consider a bolus of 0.5-2 mg/kg IV furosemide at the end of albumin infusions for patients with edema and hypoalbuminemia 3
Monitoring Requirements
- Regular monitoring of symptoms, urine output, renal function, and electrolytes is essential 2
- Consider bladder catheterization to accurately monitor urinary output in acute settings 3, 2
- When doses exceed 80 mg/day for prolonged periods, careful clinical observation and laboratory monitoring are particularly advisable 1
Special Considerations
Diuretic Resistance
- Diuretic resistance can occur with high doses (≥80 mg furosemide twice daily) 4
- Strategies to overcome resistance include:
Combination Therapy
- Thiazides in combination with loop diuretics may be useful in cases of diuretic resistance 3
- For volume-overloaded heart failure, thiazides (hydrochlorothiazide 25 mg) and aldosterone antagonists (spironolactone, eplerenone 25-50 mg) can be used with loop diuretics 3
Potential Adverse Effects
- Hypokalaemia, hyponatraemia, hyperuricaemia 3
- Hypovolaemia and dehydration 3
- Neurohormonal activation 3
- May increase hypotension following initiation of ACEI/ARB therapy 3
- Patients with hypotension (SBP <90 mmHg), severe hyponatremia, or acidosis are unlikely to respond well to diuretic treatment 2
Caution
- High doses of diuretics may lead to hypovolemia, hyponatremia, and increase the likelihood of hypotension when initiating ACE inhibitors or ARBs 2
- Diuretics should not be used in isolation but always combined with other guideline-directed medical therapy for heart failure that reduces hospitalizations and prolongs survival 3